Chronic graft-versus-host-disease-like dermopathy in a child with CD4+cell microchimerism

被引:27
作者
Kowalzick, L
Artlett, CM
Thoss, K
Baum, HP
Ziegler, H
Mischke, D
Blum, R
Martin-Pönninghaus, J
Quietzsch, J
机构
[1] Humaine Vogtland Klinikum Plauen GmbH, Dept Dermatol & Allergol, DE-08505 Plauen, Germany
[2] Humaine Vogtland Klinikum Plauen GmbH, Dept Pediat & Adolescence Med, Plauen, Germany
[3] Inst Pathol, Zweibrucken, Germany
[4] Thomas Jefferson Univ, Div Rheumatol, Philadelphia, PA 19107 USA
关键词
graft-versus-host disease; scleroderma; juvenile dermatomyositis; microchimerism; UVA1; phototherapy;
D O I
10.1159/000081489
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report the case of an 11-year-old boy suffering from a severe progressive chronic skin disease with clinical features of progressive systemic scleroderma, systemic lupus erythematosus and dermatomyositis. Skin biopsies revealed fibrosis and lichenoid changes and muscle biopsy a myositis. Immunohistology of the skin showed a lichen-ruber-like pattern. Despite repeated extensive investigations, no autoantibodies were detectable. Some of these findings looked like those described in juvenile dermatomyositis. Finally, it could be demonstrated that the boy showed microchimerism with approximately 1% maternal CD4+ lymphocytes in his peripheral blood leukocytes. Furthermore maternal cells could be demonstrated in inflamed muscle tissue. So a graft-versus-host-disease-like pathomechanism appears to be likely. Several systemic therapies have been used with limited success to improve the condition including corticosteroids, azathioprine, cyclosporine A and mycophenolate mofetil. A distinct improvement of erythemas and sclerosis could be achieved by means of low-dose UVA1 phototherapy which was applied with escalating single doses of 3-12 J/cm(2) for 35 consecutive days. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 21 条
[1]   Microchimerism: Fears and hopes [J].
Aractingi, S ;
Khosrotehrani, K .
DERMATOLOGY, 2005, 210 (01) :1-2
[2]  
Artlett CM, 2000, ARTHRITIS RHEUM-US, V43, P1062, DOI 10.1002/1529-0131(200005)43:5<1062::AID-ANR16>3.0.CO
[3]  
2-P
[4]   Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis [J].
Artlett, CM ;
Smith, JB ;
Jimenez, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (17) :1186-1191
[5]   Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies [J].
Artlett, CM ;
Ramos, R ;
Jiminez, SA ;
Patterson, K ;
Miller, FW ;
Rider, LG .
LANCET, 2000, 356 (9248) :2155-2156
[6]   Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum [J].
Bianchi, DW ;
Zickwolf, GK ;
Weil, GJ ;
Sylvester, S ;
DeMaria, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :705-708
[7]   APPLICATIONS OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN NON-ONCOLOGICAL DISEASES [J].
DALLAMICO, R ;
ZULIAN, F ;
MONTINI, G ;
ANDRETTA, B ;
MURER, L ;
ROSSETTI, F ;
LIVI, U ;
ZACCHELLO, G ;
ZACCHELLO, F .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 :168-172
[8]   8-METHOXYPSORALEN AND ULTRAVIOLET A THERAPY FOR CUTANEOUS MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE [J].
EPPINGER, T ;
EHNINGER, G ;
STEINERT, M ;
NIETHAMMER, D ;
DOPFER, R .
TRANSPLANTATION, 1990, 50 (05) :807-811
[9]   Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy [J].
Grundmann-Kollmann, M ;
Behrens, S ;
Gruss, C ;
Gottlöber, P ;
Peter, RU ;
Kerscher, M .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (01) :134-136
[10]   Graft-versus-host reactions in dermatology [J].
Johnsen, ML ;
Farmer, ER .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (03) :369-392